Thank you, healthcare workers, for all you do. Your determination to help others is truly inspiring. Please stay safe.
<em>Decision-IQ</em>: Diagnosing and Treating Ocular Cicatricial Pemphigoid
Decision-IQ Decision-IQ

Decision-IQ: Diagnosing and Treating Ocular Cicatricial Pemphigoid

This activity was developed by Med-IQ in collaboration with Duke Health.

Med-IQ      Duke Medicine


Maximum Credits:


Decision-IQ Decision-IQ


Maximum Credits:
Decision-IQ Decision-IQ


Maximum Credits:

Overview: In this short case-based activity, meet a 52-year-old woman who is referred to an ophthalmologist because of discomfort in her eyes and declining vision. As you move this activity, read through links to useful resources to help you make diagnostic and management decisions for this patient. Additionally, receive insights from ophthalmologist Melissa Daluvoy, MD, on recognizing early signs and symptoms of ocular cicatricial pemphigoid and learn how she would manage this patient.

CME Information:

Melissa B. Daluvoy, MD
Assistant Professor of Ophthalmology
Duke University Medical Center
Cornea, Cataract, Refractive Surgery, and External Disease
Duke Eye Center
Durham, NC

Activity Planners
Iwona Misiuta, PhD, MHA
Clinical Content Manager
Baltimore, MD
Laura Rafferty, ELS
Managing Editor
Baltimore, MD
Samantha Gordon
CME Specialist
Baltimore, MD
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI

Learning Objectives
Upon completion, participants should be able to:

  • Recognize early signs and symptoms of ocular cicatricial pemphigoid
  • Initiate appropriate therapy to help stop the progression of ocular cicatricial pemphigoid

Target Audience
This activity is intended for ophthalmologists.
Statement of Need
Ocular cicatricial pemphigoid (OCP) is a subtype of a group of systemic autoimmune diseases called mucous membrane pemphigoid. The pathophysiology of OCP is currently under investigation, and the cause of OCP is unknown. What is known is that patients with OCP vary significantly in disease severity and rate of progression, and, if left untreated, the disease progresses in 75% of patients. Untreated OCP can progress to severe conjunctival scarring and vision loss. Therefore, it is essential for ophthalmologists to promptly recognize and treat patients with OCP.
Collaboration Statement
This activity was developed by Med-IQ in collaboration with Duke Health.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medium/Method of Participation
This CME activity consists of a 0.25-credit online publication. To receive credit, read the introductory CME material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 18, 2018
Expiration Date: October 17, 2019
Estimated Time to Complete This Activity: 15 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
Melissa B. Daluvoy, MD, has indicated no real or apparent conflicts.

The peer reviewers and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
Contact Information        
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email
System Requirements



  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit:
© 2018 Med-IQ, Inc. and Duke University Health System


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.